no desc

Zaccardi Study: Comparative effectiveness of Gliclazide MR vs. Sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes​

This new study compares Gliclazide MR to Sitagliptin, head to head, with 1986 diabetics uncontrolled on metformin alone.

Gliclazide normalizes HbA1c to a better level, and in more diabetics than Sitagliptin, with equal safety!​

Download the full article

Estudio Zaccardi ING

It can also interest you


December 1, 2021
PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bi…


October 20, 2021
Interview with Dr. Alzaid : “What do you think about SUs?”


November 14, 2021
Happy Diabetes Month!
Background Vimeo Live Event

Keep up to date with our content

Subscribe to our newsletter so that you are always up to date with the news.

You can unsubscribe at any time by clicking on the link in our emails.
SERVIER CENTRAL AMERICA AND THE CARIBBEAN, S.A.Edificio Dream Plaza, Costa Del Este, Ciudad de Panamá, Panamá+507-301-0227Todo el contenido de este sitio web, es sólo para los profesionales de la salud y un uso interno del evento.
LogoCopyright © 2022 Servier University by SERVIER CENTRO AMÉRICA Y EL CARIBE, S.A.